Recombinant Human KLK15 Protein，His

KLK15, or Kallikrein-related peptidase 15, is a member of the kallikrein gene family, which comprises serine proteases implicated in various physiological and pathological processes. Research on KLK15 has gained traction due to its potential roles in cancer biology, particularly in breast cancer progression, where elevated levels of this protein have been correlated with malignancy. Moreover, KLK15 is investigated for its involvement in other conditions such as endometriosis and various reproductive functions, highlighting its significance in both health and disease. The recombinant form of KLK15 has been developed to aid in the elucidation of its biological functions and mechanisms. By generating KLK15 as a recombinant protein, researchers aim to better understand its enzymatic properties, substrate specificity, and regulatory pathways. This recombinant protein facilitates the study of KLK15’s role in cellular signaling, including its interactions with various substrates and inhibitors, thus providing insights into its potential as a biomarker for diagnosis or therapeutic target. Recent studies have begun to explore the implications of KLK15 in tumor microenvironments and its interaction with immune cells, paving the way for novel therapeutic strategies in cancer treatment. Overall, the research on KLK15 and its recombinant protein underscores its importance in advancing our understanding of disease mechanisms and developing innovative diagnostic and therapeutic approaches.